Sweden

Sofi Eriksson brings over 30 years of experience in senior finance and investment roles across global listed corporations, private equity-backed companies and high-growth businesses, including approximately 15 years within pharma and biotech.

She has extensive expertise in financial governance, M&A, value creation, capital markets and financing. Sofi has held senior roles at Pharmacia/Pfizer, Sandvik, Phadia, Bambora Group and the private equity firm Nordic Capital, and served as Group CFO of Dentalum Group. She is currently a board member of the Biotech company Modus Therapeutics Holding AB and holds board and advisory roles within Family Offices & Wealth management.

She holds a BSc/MSc in Business Administration and Economics from the Gothenburg School of Economics, with a major in International Finance and French.